Pepg class action alert: shareholder rights law firm robbins llp reminds investors of the lead plaintiff deadline in the pepgen inc. class action lawsuit

San diego, ca / access newswire / june 16, 2025 / robbins llp reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired pepgen inc. (nasdaq:pepg) securities between march 7, 2024 and march 3, 2025. pepgen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
PEPG Ratings Summary
PEPG Quant Ranking